&Partners’s First Trust Mid Cap Value AlphaDEX Fund FNK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$329K Sell
5,766
-636
-10% -$37.2K ﹤0.01% 1933
2025
Q4
$356K Sell
6,402
-370
-5% -$20.3K ﹤0.01% 1810
2025
Q3
$374K Buy
6,772
+7
+0.1% +$381 ﹤0.01% 1630
2025
Q2
$350K Sell
6,765
-1,020
-13% -$50.2K ﹤0.01% 1542
2025
Q1
$390K Buy
7,785
+1,836
+31% +$97.2K ﹤0.01% 1258
2024
Q4
$320K Buy
+5,949
New +$327K ﹤0.01% 1305

Other funds holding FNK

&Partners's FNK Position: Q1 2026 in Review

&Partners reduced its First Trust Mid Cap Value AlphaDEX Fund (FNK) stake by 9.9% in Q1 2026, selling an estimated $37.2K and leaving 5,766 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1933.

&Partners first reported a position in FNK in Q4 2024 and has held it in 6 quarters since. The position peaked at $390K in Q1 2025. 59 funds tracked by Wall St. Rank hold FNK as of Q1 2026.

  • &Partners held 5,766 shares of First Trust Mid Cap Value AlphaDEX Fund worth $329K as of Q1 2026.
  • &Partners sold 636 First Trust Mid Cap Value AlphaDEX Fund shares in Q1 2026, an estimated $37.2K.
  • First Trust Mid Cap Value AlphaDEX Fund made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1933 holding.
  • &Partners first reported a position in First Trust Mid Cap Value AlphaDEX Fund in Q4 2024 and has held it in 6 quarters since.
  • &Partners's First Trust Mid Cap Value AlphaDEX Fund position peaked at $390K in Q1 2025.
  • 59 funds tracked by Wall St. Rank held First Trust Mid Cap Value AlphaDEX Fund as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.